DAWN - Company ID 0001845337
The table below shows Day One Biopharmaceuticals, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $197.08M | $124.97M | $230.78M | $85.26M | $284.31M |
| Short-term investments | $244.03M | $406.75M | $135.56M | $257.01M | - |
| Receivables | - | - | - | - | - |
| Inventory | $6.33M | $3.32M | - | - | - |
| Total current assets | $485.10M | $562.33M | $375.27M | $347.87M | $289.37M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $2.14M | $2.29M | $208.00K | $20.00K | $57.00K |
| Goodwill | - | - | - | - | - |
| Total assets | $507.83M | $582.79M | $376.05M | $349.06M | $289.82M |
| Accounts payable | $3.73M | $3.26M | $2.58M | $260.00K | $1.74M |
| Total current liabilities | $60.52M | $73.45M | $29.51M | $16.61M | $8.66M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $66.67M | $80.04M | $29.51M | $17.02M | $8.67M |
| Retained earnings | -$661.40M | -$554.08M | -$458.58M | -$269.67M | -$127.49M |
| Total equity | $441.16M | $502.75M | $346.54M | $332.04M | $281.15M |